Idenix Pharmaceuticals, created in 1998 (United States), from 402 sister brands and 17477 competing brands. The Idenix Pharmaceuticals brand is owned by Merck & Co, a company listed in New York. The sector of Idenix Pharmaceuticals is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Merck & Co
(Idenix Pharmaceuticals)
over 5 years*
USD 219.60